Portfolio company
Form Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company provides a software platform using artificial intelligence to help biopharmaceutical organisations and researchers design and optimise cell and gene therapies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Tolemy Bio
This company develops an AI platform to model and optimise cellular behaviour for biotechnology and pharmaceutical organisations developing advanced therapies.
expressionedits
This company develops a computational platform using artificial intelligence to optimise gene design and enhance protein production for biotechnology and pharmaceutical organisations.
ZipBio
The company develops artificial intelligence to design gene therapies for pharmaceutical firms and biotechnology researchers.
Formation Bio
This company develops in-licensed clinical-stage drug candidates for pharmaceutical and biotechnology partners using a proprietary artificial intelligence platform to accelerate trials.
Profluent
This company develops generative artificial intelligence models to design novel proteins and gene editors for pharmaceutical, biotechnology and agricultural organisations.
310.ai
This company develops generative artificial intelligence models to design novel proteins and biomolecules for pharmaceutical and biotechnology organisations.
Whitelab Genomics
Whitelab Genomics develops an AI-powered software platform for designing and optimising genomic medicines for biotechnology companies, pharmaceutical firms, and academic research organisations.
Transforming cells into cures
This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.